Han Zhu

666 total citations
29 papers, 386 citations indexed

About

Han Zhu is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Han Zhu has authored 29 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Han Zhu's work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (4 papers) and CAR-T cell therapy research (3 papers). Han Zhu is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (4 papers) and CAR-T cell therapy research (3 papers). Han Zhu collaborates with scholars based in China, United States and Macao. Han Zhu's co-authors include Jianyong Li, Sixuan Qian, Ming Hong, Huihui Zhao, Shuai Wang, Lulu Yang, Jianping Mao, Bao Wang, Bin Zhou and Ninghan Tang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Carcinogenesis.

In The Last Decade

Han Zhu

23 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han Zhu China 12 175 103 80 55 52 29 386
Jung Hye Choi South Korea 12 144 0.8× 87 0.8× 68 0.8× 20 0.4× 43 0.8× 41 398
Mohamed El‐Shanshory Egypt 11 73 0.4× 99 1.0× 83 1.0× 14 0.3× 42 0.8× 41 399
Elizabeth A. McCart United States 12 114 0.7× 39 0.4× 34 0.4× 26 0.5× 38 0.7× 17 384
Sara A. Monaghan United States 9 185 1.1× 223 2.2× 100 1.3× 139 2.5× 16 0.3× 32 527
Ewa Gińdzieńska‐Sieśkiewicz Poland 10 168 1.0× 38 0.4× 40 0.5× 17 0.3× 35 0.7× 34 427
Philipp Houben Germany 10 98 0.6× 75 0.7× 38 0.5× 13 0.2× 22 0.4× 36 408
Jie Bai China 15 336 1.9× 252 2.4× 50 0.6× 25 0.5× 119 2.3× 76 635
S.P. Stoesz United States 6 212 1.2× 50 0.5× 45 0.6× 19 0.3× 61 1.2× 7 437
Lucía Tejedor-Santamaria Spain 10 172 1.0× 29 0.3× 26 0.3× 36 0.7× 19 0.4× 22 415
Hadi Rezaeeyan Iran 12 115 0.7× 62 0.6× 62 0.8× 9 0.2× 64 1.2× 37 367

Countries citing papers authored by Han Zhu

Since Specialization
Citations

This map shows the geographic impact of Han Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Zhu more than expected).

Fields of papers citing papers by Han Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Zhu. The network helps show where Han Zhu may publish in the future.

Co-authorship network of co-authors of Han Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Han Zhu. A scholar is included among the top collaborators of Han Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Zhu. Han Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jing, Wenqi Wang, Sanwei Hao, et al.. (2025). Robust and Biodegradable Heterogeneous Electronics with Customizable Cylindrical Architecture for Interference-Free Respiratory Rate Monitoring. Nano-Micro Letters. 18(1). 34–34. 1 indexed citations
2.
Sun, Meng, Han Zhu, Yu Yang, et al.. (2025). Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review). International Journal of Oncology. 66(5). 1–22.
3.
Zhu, Han, et al.. (2024). Recent Progresses in the Multimodality Imaging Assessment of Myocardial Fibrosis. Reviews in Cardiovascular Medicine. 25(1). 5–5. 1 indexed citations
5.
Meng, Haiyang, et al.. (2023). Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study. International Journal of Antimicrobial Agents. 62(4). 106933–106933. 12 indexed citations
6.
Mi, Jian‐Qing, Wanhong Zhao, Lijuan Chen, et al.. (2023). P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2. HemaSphere. 7(S3). e9841889–e9841889. 1 indexed citations
7.
Zhang, Xiao, Yan Liu, Fang Li, et al.. (2022). Risk factors and survival of refractory cytomegalovirus reactivation after allogeneic peripheral blood stem cell transplantation. Journal of Global Antimicrobial Resistance. 31. 279–285. 4 indexed citations
8.
Shen, Xing, Jing Pan, Feng Yuan, et al.. (2021). Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia. Hematology. 26(1). 295–300. 3 indexed citations
9.
Zhang, Lina, Shuai Wang, Ji Xu, et al.. (2021). Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy. Experimental Hematology and Oncology. 10(1). 16–16. 41 indexed citations
10.
Hu, Hao, Huanhuan Chen, Wen Chen, et al.. (2020). T2 mapping histogram at extraocular muscles for predicting the response to glucocorticoid therapy in patients with thyroid-associated ophthalmopathy. Clinical Radiology. 76(2). 159.e1–159.e8. 13 indexed citations
11.
Hong, Ming, Han Zhu, Qian Sun, et al.. (2020). Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML. Aging. 12(7). 5792–5811. 21 indexed citations
12.
Xu, Min, Xiaoli Zhao, Wenyi Shen, et al.. (2018). ND4 mutations are more prevalent in patients with acute myeloid leukemia of M2 morphology. Translational Cancer Research. 7(4). 1064–1071. 1 indexed citations
13.
15.
Mao, Jianping, Shan Li, Huihui Zhao, et al.. (2018). Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.. PubMed. 10(8). 2567–2578. 28 indexed citations
16.
Hong, Ming, Shuai Wang, Han Zhu, et al.. (2017). Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases. Blood. 130. 5230–5230. 2 indexed citations
18.
Hong, Ming, Yi Xia, Yu Zhu, et al.. (2016). TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia. Leukemia Research. 50. 72–77. 20 indexed citations
19.
Wang, Wenyu, et al.. (2011). Effect of autophagy-related gene Beclin 1 on growth of xenografts of human lung adenocarcinoma A549 cells in nude mice. Tumori. 31(12). 1061–1066. 1 indexed citations
20.
Zhu, Han, et al.. (2006). Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis. 27(12). 2491–2496. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026